CDK4 and cancer: CDK4 and CDK6 are crucial for cell cycle regulation and are attractive targets for the treatments of various types of cancers, including GB, frequently characterized by a CDK4/6 pathway dysregulation (Network 2008; Brennan et al., 2013; Bronner et al., 2019).